McBarron Paul's most recent trade in Cyclacel Pharmaceuticals Inc was a trade of 1,886 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on Dec. 21, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cyclacel Pharmaceuticals Inc | Paul McBarron | Director, See Remarks | 21 Dec 2023 | 1,886 | 33,378 (0%) | 0% | 3.3 | 6,252 | Common Stock | |
Cyclacel Pharmaceuticals Inc | McBarron Paul | Director, See Remarks | 21 Dec 2023 | 1,886 | 1,886 | - | - | Warrants (right to buy) | ||
Cyclacel Pharmaceuticals Inc | Paul McBarron | Director, See Remarks | 30 Jun 2023 | 70,200 | 70,200 | - | - | Stock Option (right to buy) | ||
Cyclacel Pharmaceuticals Inc | Paul McBarron | Director, See Remarks | 31 Jan 2023 | 31,200 | 31,492 (0%) | 0% | 0 | Common Stock | ||
Cyclacel Pharmaceuticals Inc | Paul McBarron | Director, See Remarks | 13 Dec 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | ||
Cyclacel Pharmaceuticals Inc | Paul McBarron | Director, See Remarks | 11 Dec 2020 | 120,000 | 120,000 | - | - | Stock Option (right to buy) |